256 related articles for article (PubMed ID: 15692962)
1. Thrombotic thrombocytopenic purpura in the setting of systemic sclerosis.
Manadan AM; Harris C; Block JA
Semin Arthritis Rheum; 2005 Feb; 34(4):683-8. PubMed ID: 15692962
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
Shibagaki Y; Fujita T
Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
[TBL] [Abstract][Full Text] [Related]
3. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
Furlan M; Lämmle B
Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
[TBL] [Abstract][Full Text] [Related]
4. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
[TBL] [Abstract][Full Text] [Related]
5. [Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura].
Masset C; Dubois B; Rorive G
Rev Med Liege; 2002 Jan; 57(1):33-9. PubMed ID: 11899496
[TBL] [Abstract][Full Text] [Related]
6. Relapsed thrombotic thrombocytopenic purpura presenting as an acute cerebrovascular accident.
Downes KA; Yomtovian R; Tsai HM; Silver B; Rutherford C; Sarode R
J Clin Apher; 2004; 19(2):86-9. PubMed ID: 15274201
[TBL] [Abstract][Full Text] [Related]
7. The von Willebrand factor-cleaving protease (ADAMTS-13) and the diagnosis of thrombotic thrombocytopenic purpura (TTP).
Kremer Hovinga JA; Studt JD; Lämmle B
Pathophysiol Haemost Thromb; 2003 Sep-2004 Dec; 33(5-6):417-21. PubMed ID: 15692254
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic thrombocytopenic purpura associated with severe acute pancreatitis in a context of decreased ADAMTS13 activity: a case report.
Piton G; Navellou JC; Morati P; Patry C; Carbonnel F; Capellier G
Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1226-30. PubMed ID: 18989146
[TBL] [Abstract][Full Text] [Related]
9. [Thrombotic thrombocytopenic purpura. Reduced activity of von Willebrand factor cleaving protease].
Kunze A; Terborg C; Gerth J; Heide G; Witte OW
Nervenarzt; 2004 Aug; 75(8):785-9. PubMed ID: 15034657
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.
Tsai HM; Lian EC
N Engl J Med; 1998 Nov; 339(22):1585-94. PubMed ID: 9828246
[TBL] [Abstract][Full Text] [Related]
11. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP).
Gerritsen HE; Turecek PL; Schwarz HP; Lämmle B; Furlan M
Thromb Haemost; 1999 Nov; 82(5):1386-9. PubMed ID: 10595623
[TBL] [Abstract][Full Text] [Related]
12. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
Furlan M
Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):243-55. PubMed ID: 15030284
[TBL] [Abstract][Full Text] [Related]
13. The "cutting" edge: von Willebrand factor-cleaving protease activity in thrombotic microangiopathies.
Haspel RL; Jarolím P
Transfus Apher Sci; 2005 Apr; 32(2):177-84. PubMed ID: 15784452
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
15. Atypical presentations of thrombotic thrombocytopenic purpura: a review.
Sarode R
J Clin Apher; 2009; 24(1):47-52. PubMed ID: 19073011
[TBL] [Abstract][Full Text] [Related]
16. Systemic sclerosis with thrombotic thrombocytopenia purpura and malignant hypertension.
Yang Y; Zhang L; Tang Y; Zhao Y; Su B; Fu P
Ren Fail; 2012; 34(9):1170-2. PubMed ID: 22871138
[TBL] [Abstract][Full Text] [Related]
17. Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS).
Licht C; Stapenhorst L; Simon T; Budde U; Schneppenheim R; Hoppe B
Kidney Int; 2004 Sep; 66(3):955-8. PubMed ID: 15327386
[TBL] [Abstract][Full Text] [Related]
18. von Willebrand factor and its cleaving protease ADAMTS13 balance in coronary artery vessels: Lessons learned from thrombotic thrombocytopenic purpura. A narrative review.
Morici N; Cantoni S; Panzeri F; Sacco A; Rusconi C; Stucchi M; Oliva F; Cattaneo M
Thromb Res; 2017 Jul; 155():78-85. PubMed ID: 28521259
[TBL] [Abstract][Full Text] [Related]
19. [Clinical features and laboratory findings of thrombotic thrombocytopenic purpura associated with ticlopidine].
Yagi H
Rinsho Byori; 2005 Jul; 53(7):630-8. PubMed ID: 16104532
[TBL] [Abstract][Full Text] [Related]
20. Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura.
Furlan M; Robles R; Morselli B; Sandoz P; Lämmle B
Thromb Haemost; 1999 Jan; 81(1):8-13. PubMed ID: 10348715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
